What is the difference between a CT scan and a PET scan for CLL
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
CT Scan vs. PET Scan for CLL: What's the Difference?
Both CT and PET scans are imaging tests that help your oncology team evaluate CLL, but they work in very different ways and provide different information.
CT Scan (Computed Tomography)
A CT scan takes detailed X-ray pictures from many angles to create cross-sectional images of your body. Think of it like slicing through your body and looking at each slice.
What it shows:
- The size and location of lymph nodes, spleen, and liver
- The structure of organs and tissues
- Whether lymph nodes are enlarged
What it's good for:
- Measuring how big your lymph nodes are
- Detecting physical changes in organs
- Providing a baseline to compare future scans
PET Scan (Positron Emission Tomography)
A PET scan works completely differently. You receive an injection of a radioactive tracer (usually a form of glucose/sugar) that travels through your body. Cancer cells typically use more glucose than normal cells, so they "light up" on the scan.
What it shows:
- Which areas are metabolically active (using more energy/glucose)
- How aggressive or active the disease appears
- Whether cancer is present in areas that might look normal on a CT
What it's good for:
- Detecting disease activity
- Identifying transformation (a serious complication in CLL)
Why This Matters for CLL Patients
According to the NCCN Guidelines for CLL, PET scans play a particularly important role in detecting Richter transformation—a serious complication where CLL transforms into a more aggressive lymphoma (DLBCL).
Here's the key finding: A PET scan measurement called SUVmax (maximum standardized uptake value) ≥10 has been shown to be a valid marker for distinguishing Richter transformation from regular CLL in patients treated with chemotherapy or chemoimmunotherapy. However, the guidelines note an important caveat: PET alone is not sufficient—if your doctor suspects transformation, a lymph node biopsy is still needed for definitive diagnosis, especially if you're on BTK inhibitors like ibrutinib.
How Doctors Use Them Together
Your oncology team typically uses both scans together:
- CT scan = measures the physical size of disease
- PET scan = shows how active the disease is
According to NCCN Guidelines, when evaluating for possible Richter transformation, doctors recommend whole-body PET/CT scan (both together) or chest/abdomen/pelvis CT with contrast. The PET helps identify which lymph nodes have the highest activity, and then biopsies are directed to those areas with highest FDG uptake.
Questions to Ask Your Doctor
If your oncologist recommends imaging:
- "Which scan are you ordering and why—are you looking for size changes, disease activity, or both?"
- "If I have a PET scan, what SUV values are you looking for, and what would they mean?"
- "Will you be comparing this to my previous scans to track changes?"
- "If anything concerning shows up on imaging, what's the next step?"
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Chronic Lymphocytic Leukemia (2026)Browse all NCCN Guidelines for Patients →Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: